In the second part of this two-part series, we look at our work with industry, why it’s important, and how we try to influence the way drugs get to patients.
In this first in a two-part series, we take a look at how cancer drugs get to patients, and at some of reasons behind the spiralling costs.
We cover the latest cancer research, including that funded by the charity. We also highlight other relevant material, debunk myths and media scares, and provide links to other helpful resources.
Text from Cancer Research UK Science blog by Cancer Research UK, is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License.